• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为胞质磷脂酶A2α和脂肪酸酰胺水解酶抑制剂的1-杂芳基-3-苯氧基丙-2-酮的构效关系研究:用其他丝氨酸陷阱取代活化的酮基。

Structure-activity relationship studies on 1-heteroaryl-3-phenoxypropan-2-ones acting as inhibitors of cytosolic phospholipase A2α and fatty acid amide hydrolase: replacement of the activated ketone group by other serine traps.

作者信息

Sundermann Tom, Hanekamp Walburga, Lehr Matthias

机构信息

a Department of Chemistry and Pharmacy , Institute of Pharmaceutical and Medicinal Chemistry, University of Münster , Münster , Germany.

出版信息

J Enzyme Inhib Med Chem. 2016 Aug;31(4):653-63. doi: 10.3109/14756366.2015.1057721. Epub 2015 Jul 7.

DOI:10.3109/14756366.2015.1057721
PMID:26153239
Abstract

Cytosolic phospholipase A2α (cPLA2α) and fatty acid amide hydrolase (FAAH) are serine hydrolases. cPLA2α is involved in the generation of pro-inflammatory lipid mediators, FAAH terminates the anti-inflammatory effects of endocannabinoids. Therefore, inhibitors of these enzymes may represent new drug candidates for the treatment of inflammation. We have reported that certain 1-heteroarylpropan-2-ones are potent inhibitors of cPLA2α and FAAH. The serine reactive ketone group of these compounds, which is crucial for enzyme inhibition, is readily metabolized resulting in inactive alcohol derivatives. In order to obtain metabolically more stable inhibitors, we replaced this moiety by α-ketoheterocyle, cyanamide and nitrile serine traps. Investigations on activity and metabolic stability of these substances revealed that in all cases an increased metabolic stability was accompanied by a loss of inhibitory potency against cPLA2α and FAAH, respectively.

摘要

胞质型磷脂酶A2α(cPLA2α)和脂肪酸酰胺水解酶(FAAH)属于丝氨酸水解酶。cPLA2α参与促炎脂质介质的生成,FAAH则终止内源性大麻素的抗炎作用。因此,这些酶的抑制剂可能成为治疗炎症的新型候选药物。我们曾报道某些1-杂芳基丙烷-2-酮是cPLA2α和FAAH的强效抑制剂。这些化合物的丝氨酸反应性酮基对酶抑制作用至关重要,但极易被代谢,生成无活性的醇衍生物。为了获得代谢稳定性更高的抑制剂,我们用α-酮杂环、氰胺和腈丝氨酸捕获剂取代了该基团。对这些物质的活性和代谢稳定性进行研究后发现,在所有情况下,代谢稳定性的提高都分别伴随着对cPLA2α和FAAH抑制效力的丧失。

相似文献

1
Structure-activity relationship studies on 1-heteroaryl-3-phenoxypropan-2-ones acting as inhibitors of cytosolic phospholipase A2α and fatty acid amide hydrolase: replacement of the activated ketone group by other serine traps.作为胞质磷脂酶A2α和脂肪酸酰胺水解酶抑制剂的1-杂芳基-3-苯氧基丙-2-酮的构效关系研究:用其他丝氨酸陷阱取代活化的酮基。
J Enzyme Inhib Med Chem. 2016 Aug;31(4):653-63. doi: 10.3109/14756366.2015.1057721. Epub 2015 Jul 7.
2
1-(5-Carboxyindazol-1-yl)propan-2-ones as dual inhibitors of cytosolic phospholipase Aα and fatty acid amide hydrolase: bioisosteric replacement of the carboxylic acid moiety.1-(5-羧基吲唑-1-基)丙烷-2-酮作为胞质磷脂酶Aα和脂肪酸酰胺水解酶的双重抑制剂:羧酸部分的生物电子等排体替代
J Enzyme Inhib Med Chem. 2016;31(sup1):131-140. doi: 10.1080/14756366.2016.1178246. Epub 2016 May 9.
3
1-Heteroaryl-3-phenoxypropan-2-ones as inhibitors of cytosolic phospholipase A₂α and fatty acid amide hydrolase: Effect of the replacement of the ether oxygen with sulfur and nitrogen moieties on enzyme inhibition and metabolic stability.1-杂芳基-3-苯氧基丙-2-酮作为胞质磷脂酶A₂α和脂肪酸酰胺水解酶的抑制剂:用硫和氮部分取代醚氧对酶抑制和代谢稳定性的影响。
Bioorg Med Chem. 2015 May 15;23(10):2579-92. doi: 10.1016/j.bmc.2015.03.033. Epub 2015 Mar 21.
4
1-(3-biaryloxy-2-oxopropyl)indole-5-carboxylic acids and related compounds as dual inhibitors of human cytosolic phospholipase A2α and fatty acid amide hydrolase.1-(3-二芳基氧基-2-氧代丙基)吲哚-5-羧酸及其相关化合物作为人胞质型磷脂酶 A2α 和脂肪酸酰胺水解酶的双重抑制剂。
ChemMedChem. 2011 Mar 7;6(3):544-9. doi: 10.1002/cmdc.201000473. Epub 2011 Jan 21.
5
1-Heteroarylpropan-2-ones as inhibitors of fatty acid amide hydrolase: Studies on structure-activity relationships and metabolic stability.1-杂芳基丙烷-2-酮作为脂肪酸酰胺水解酶抑制剂:构效关系和代谢稳定性研究
Bioorg Med Chem. 2017 Feb 1;25(3):825-837. doi: 10.1016/j.bmc.2016.11.025. Epub 2016 Nov 15.
6
1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.1-吲哚基-1-丙-2-酮类化合物及其相关杂环化合物作为细胞溶质磷脂酶 A2alpha 和脂肪酸酰胺水解酶的双重抑制剂。
Bioorg Med Chem. 2010 Jan 15;18(2):945-52. doi: 10.1016/j.bmc.2009.11.028. Epub 2009 Nov 17.
7
Design and synthesis of 1-indol-1-yl-propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha.作为人胞质磷脂酶A2α抑制剂的1-吲哚-1-基-丙-2-酮的设计与合成
J Med Chem. 2006 Apr 20;49(8):2611-20. doi: 10.1021/jm051243a.
8
Design of novel and potent cPLA2α inhibitors containing an α-methyl-2-ketothiazole as a metabolically stable serine trap.设计新型强效 cPLA2α 抑制剂,其中包含作为代谢稳定丝氨酸陷阱的 α-甲基-2-酮噻唑。
Bioorg Med Chem Lett. 2011 May 15;21(10):3128-33. doi: 10.1016/j.bmcl.2011.03.005. Epub 2011 Mar 6.
9
Synthesis, activity, metabolic stability and cell permeability of new cytosolic phospholipase Aα inhibitors with 1-indolyl-3-phenoxypropan-2-one structure.
Bioorg Med Chem Lett. 2023 Aug 15;92:129374. doi: 10.1016/j.bmcl.2023.129374. Epub 2023 Jun 13.
10
Targeting Cytosolic Phospholipase A2α for Novel Anti-Inflammatory Agents.针对细胞溶质磷脂酶 A2α的新型抗炎药物。
Curr Med Chem. 2018;25(21):2418-2447. doi: 10.2174/0929867325666180117103919.

引用本文的文献

1
Terminal Phenoxy Group as a Privileged Moiety of the Drug Scaffold-A Short Review of Most Recent Studies 2013-2022.端酚氧基作为药物支架的优势部分——对 2013 年至 2022 年最新研究的综述。
Int J Mol Sci. 2022 Aug 9;23(16):8874. doi: 10.3390/ijms23168874.
2
Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A.小分子抑制剂作为潜在的治疗药物和研究磷脂酶 A 作用的工具。
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun;1864(6):941-956. doi: 10.1016/j.bbalip.2018.08.009. Epub 2018 Aug 23.